ARTRYA LIMITED — Director's Dealing 2023

Dec 18, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Artrya Limited ACN 624 005 741

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Jacque Sokolov
Date of last notice	10 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in thispart.
Direct or indirect interest	Direct and Indirect
Nature of indirect interest	Jacque J Sokolov Inc. Defined Benefit
(including registered holder)	Pension Plan
Note: Provide details of the circumstances giving rise to the relevant
interest.
	(Jacque Sokolov is a beneficiaryof theplan)
Date of change	18	December 2023
No. of securities held prior to change
Dr Jacque J Sokolov		•1,300,000 unlisted options; expiry
		13.01.2027; exercisable at $1.35
		•1,300,000 unlisted options; expiry
		13.01.2027; exercisable at $3.00
		•1,300,000 unlisted options; expiry
		13.01.2027; exercisable at $5.00
Class	Ordinary Shares (ORD)
Number acquired	330,000 ordinary shares
Number disposed	-
Value/Consideration	$49,500
Note: If consideration is non-cash, provide details and estimated
valuation

• See chapter 19 for defined terms.

01/01/2011Appendix

3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after changeDr Jacque SokolovJacque J Sokolov Inc. Defined Benefit PensionPlan	•1,300,000 unlisted options; expiry13.01.2027; exercisable at $1.35•1,300,000 unlisted options; expiry13.01.2027; exercisable at $3.00•1,300,000 unlisted options; expiry13.01.2027; exercisable at $5.00•330,000 Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Off-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 2